勘误：治疗性酶人胸苷磷酸化酶的重组表达工程及聚乙二醇化效率
Erratum: Engineering of the Recombinant Expression and PEGylation Efficiency of the Therapeutic Enzyme Human Thymidine Phosphorylase.
机构信息
Frontiers Media SA, Lausanne, Switzerland.
出版信息
Front Bioeng Biotechnol. 2022 Mar 11;10:878674. doi: 10.3389/fbioe.2022.878674. eCollection 2022.
Abstract
[This corrects the article DOI: 10.3389/fbioe.2021.793985.].
摘要
[本文更正了文章的数字对象标识符：10.3389/fbioe.2021.793985。]
相似文献
1
Erratum: Engineering of the Recombinant Expression and PEGylation Efficiency of the Therapeutic Enzyme Human Thymidine Phosphorylase.勘误：治疗性酶人胸苷磷酸化酶的重组表达工程及聚乙二醇化效率
Front Bioeng Biotechnol. 2022 Mar 11;10:878674. doi: 10.3389/fbioe.2022.878674. eCollection 2022.
2
Engineering of the Recombinant Expression and PEGylation Efficiency of the Therapeutic Enzyme Human Thymidine Phosphorylase.治疗性酶人胸苷磷酸化酶的重组表达及聚乙二醇化效率工程
Front Bioeng Biotechnol. 2021 Dec 17;9:793985. doi: 10.3389/fbioe.2021.793985. eCollection 2021.
3
Identification of 1,2,4-triazoles as new thymidine phosphorylase inhibitors: Future anti-tumor drugs.鉴定 1,2,4-三唑类化合物为新型胸苷磷酸化酶抑制剂：未来的抗肿瘤药物。
Bioorg Chem. 2019 Apr;85:209-220. doi: 10.1016/j.bioorg.2019.01.005. Epub 2019 Jan 4.
4
2-Arylquinazolin-4(3H)-ones: A novel class of thymidine phosphorylase inhibitors.2-芳基喹唑啉-4(3H)-酮：一类新型胸苷磷酸化酶抑制剂。
Bioorg Chem. 2015 Dec;63:142-51. doi: 10.1016/j.bioorg.2015.10.006. Epub 2015 Oct 29.
5
Validation of an Immunoassay for Anti-thymidine Phosphorylase Antibodies in Patients with MNGIE Treated with Enzyme Replacement Therapy.接受酶替代疗法治疗的MNGIE患者抗胸苷磷酸化酶抗体免疫测定的验证
Mol Ther Methods Clin Dev. 2018 Aug 28;11:1-8. doi: 10.1016/j.omtm.2018.08.007. eCollection 2018 Dec 14.
6
Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity.血小板衍生内皮细胞生长因子在大肠杆菌中的表达及其胸苷磷酸化酶活性的确认。
Biochemistry. 1992 Dec 8;31(48):12141-6. doi: 10.1021/bi00163a024.
7
Optimum induction of recombinant thymidine phosphorylase and its application.重组胸苷磷酸化酶的最佳诱导及其应用。
Nucleosides Nucleotides Nucleic Acids. 2011 May;30(5):360-8. doi: 10.1080/15257770.2011.587858.
8
Induction of thymidine phosphorylase by interferon and taxanes occurs only in human cancer cells with low thymidine phosphorylase activity.干扰素和紫杉烷诱导胸苷磷酸化酶仅发生在胸苷磷酸化酶活性较低的人类癌细胞中。
Cancer Lett. 2002 Dec 10;187(1-2):103-10. doi: 10.1016/s0304-3835(02)00358-0.
9
10
Synthesis, evaluation of thymidine phosphorylase and angiogenic inhibitory potential of ciprofloxacin analogues: Repositioning of ciprofloxacin from antibiotic to future anticancer drugs.合成、评估胸苷磷酸化酶和环丙沙星类似物的血管生成抑制潜力：将环丙沙星从抗生素重新定位为未来的抗癌药物。
Bioorg Chem. 2020 Jul;100:103876. doi: 10.1016/j.bioorg.2020.103876. Epub 2020 Apr 22.
Zotero 插件